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Osh4 is an oxysterol binding protein homologue found in yeast that is essential for the 
intracellular transport of sterols. It has been proposed that Osh4 acts as a lipid transport 
protein, binding a single sterol residue and transporting it from the endoplasmic reticulum 
to the plasma membrane. The dynamics of Osh4 as well as ergosterol binding was 
observed using molecular dynamics simulations. Blind docking of several model lipid 
head group moieties was used to detect potential binding regions along the Osh4 surface 
favorable towards phospholipid interaction. Models frequently docked to a lysine-rich 
region on the side of the protein’s -barrel. A model ergosterol-containing membrane 
system for yeast was also constructed and simulated using molecular dynamics, and an 
improvement to the deuterium order parameters was observed over previous models. 
Understanding how Osh4 attaches to cellular membranes will lead to a clear 
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CHAPTER 1 – BACKGROUND 
 
1.1 Intracellular Sterol Transport 
1.1.1 Sterols and their Cellular Distribution 
Sterols are a subgroup of steroids that are characterized by three parts: a ring 
region consisting of three six-membered rings and one five-membered ring, a 
hydrophobic tail region extending from the five-membered ring at the C27 carbon, and a 
hydroxyl group on the C3 ring carbon (Figure 1.1). Cholesterol, which is found in human 
and other mammalian cells, is highly important to both the form and function of cellular 
membranes. Given its rigid, flat, and hydrophobic ring structure, the concentration of 
cholesterol in a membrane can regulate membrane fluidic properties.
2
 Furthermore, 
cholesterol has been implicated in many transmembrane signaling and trafficking 
processes.
2
 Human cells are able to acquire cholesterol from two sources: dietary intake 
and de novo synthesis within the endoplasmic reticulum (ER).
2
 The exact ratio of total 
body cholesterol synthesized versus that obtained from dietary sources varies from each 
individual, but is estimated to be approximately 70:30.
3
  
Yeast (Saccharomyces cerivisiae), which is an established model organism for the 
study of biological sterol transport, does not uptake sterols from its environment under 
aerobic conditions and, instead, relies solely on sterol production through biosynthesis in 
the ER.
2; 4
 Unlike in human and other mammalian cells, the dominant sterol in yeast and 
other fungi is ergosterol. While ergosterol is structurally similar to cholesterol, a few key 
differences exist in both the ring and tail regions (Figure 1.1). Namely, the ergosterol ring 
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structure is more ridged on account of an additional double bond on the B ring. The 
ergosterol tail is more ridged as well because of the presence of a double bond. An 
additional methyl group attached to the C24 carbon is also present on the ergosterol tail. 
While the differences in structure between cholesterol and ergosterol may be similar, 




Sterol concentrations are not homogeneous across different organelles within the 
cell. The plasma membrane (PM) contains the highest sterol concentration, constituting 
~35-40% of the membrane’s lipid content by molecular concentration in eukaryotic 
cells.
6
 Conversely, sterol concentration in the ER is significantly lower, constituting only 
~1-10% of membrane lipid molecules.
4
 Transferring sterols from the ER to the PM, as 
well as other membranes within the cell, would result in equilibrated sterol 
concentrations if it were not for a highly precise sorting mechanism.
7
 The cellular 
processes governing the synthesis, sorting, and transport of cholesterol and other 
biologically important sterols are highly complex and, unfortunately, poorly understood. 
Mechanisms for sterol trafficking can be divided into two general classifications; 
Figure 1.1 – Structures of cholesterol and ergosterol. Rings and selected carbons are labeled using the 
IUPAC recommended numbering scheme for a steroids. 
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vesicular and non-vesicular mechanisms. These two mechanisms will be discussed in the 
following two subsections. 
1.1.2 Vesicular Transport Mechanisms 
 One pathway for sterol transport is along the protein secretory pathway, which 
crosses through the Golgi.
6
 Sterols are transferred to the trans-Golgi network (TGN) at a 
direct membrane contact site formed between the ER and the TGN.
2
 In the TGN, sterols 
associate with sphingolipids to form lipid raft microdomains.
7
 Lipid rafts are regions on 
the exoplasmic leaflet consisting of sphingolipids and sterols with sterols packed in 
between the spaces of the sphingolipid saturated chains.
8
 These domains are saturated 
with sterols when compared to other regions on the membrane.
9
 Lipid rafts are thought to 
exist in the liquid-ordered phase, distinct from the liquid-disordered phase in the other, 
more loosely packed portions of the membrane.
8
 These lipid rafts are transported from 
the TGN to the PM through secretory vesicles (SVs), along with proteins and sterol poor 
domains. Vesicles are carried to the PM over cytoskeleton tracks in a manner dependent 
on ATP.
2
 However, disruption of the cytoskeleton has shown no effect on rapid sterol 
transport between the ER and PM and Golgi disassembly only decreases nascent 
cholesterol transport by ~20% in cells.
6
 Therefore, sterols are not trafficked from the ER 
to the PM by vesicular means alone and sterol transport along the secretory pathway 
appears to play only a minor role in intracellular sterol trafficking. A diagram of 
intracellular sterol transport pathways is shown in Figure 1.2, with the vesicular pathway 




1.1.3 Non-vesicular Transport Mechanisms 
 The major pathway in which cholesterol is transferred from the ER to the PM is 
likely through non-vesicular mechanisms.
6
 Lipid transport between membranes through 
lipid transport proteins (LTPs) has previously been identified for other lipids, such as the 
transport of ceramide via the ceramide transfer protein (CERT).
10
 While the mechanisms 
by which proteins can extract and transfer sterols between membranes in vivo remains 
unknown, several families of proteins have demonstrated the ability to extract and 
transfer sterols between membranes in vitro. One such protein, the steroidogenic acute 
regulatory protein (StAR) is necessary for the efficient transport of cholesterol from the 
outer mitochondrial membrane to the inner mitochondrial membrane.
11
 Another protein, 
NCP2, has shown the ability to bind with cholesterol. Mutations in either the NPC1 or 
Figure 1.2 – Some proposed mechanisms of intracellular ER to PM sterol transport. The vesicular 




NPC2 genes are the cause of Niemann Pick Type C disease, a rare disorder that affects 
cholesterol storage.
11
 The oxysterol-binding protein (OSBP) and its related proteins 
(ORPs) form a family of LTPs in humans and other mammals are grouped together based 
on the presence of an OSBP-related domain (ORD).
11
 There are at least twelve ORPs 
encoded in mammals.
7
 While the function of many of these proteins remains unknown, 




 Yeast contains seven ORPs, known collectively as Osh (OSBP-homolog) 
proteins.
11
 Unlike mammals, yeast does not posses StAR or NPC2 proteins, suggesting 
that the Osh proteins are responsible for non-vesicular sterol regulation and transfer 
(Figure 1.2, black arrows).
12
 The deletion of all seven Osh genes results in death, but the 
organism remains viable, though with impaired function, if only one Osh gene is present 
suggesting an overlapping function between all Osh proteins.
13
 The most abundant Osh 
protein, Osh4, has been shown to transfer sterols between donor and acceptor vesicles in 
vitro, with transfer stimulated in the presence of phospoinosides (PIPs).
14
 Background 
information specific to the Osh4 protein is presented in Section 2.1.  
1.2 Computational Techniques 
While computational techniques have been employed in biological research for 
decades, the recent explosion in new technology and faster computer hardware has 
greatly expanded the boundaries of what researchers are capable of achieving in silico. 
While there are many applications for computer aided modeling within the realm of 
biochemistry and molecular biology, two techniques are presented within this subsection: 
Molecular dynamics (MD) simulation and docking. MD is often used to view the 
6 
 
dynamical properties of biomolecules while also providing thermal averages of relevant 
molecular properties through use of the ergodic hypothesis.
15
 However, given the large 
computational expense attributed to long range interactions in systems with tens of 
thousands or more components, MD is inherently slow. Docking, which is often used in 
the virtual screening of pharmaceutical compounds as well as binding site identification 
along a protein surface, is much quicker than MD but is more limited in application. The 
underlying theories behind each technique are presented below. 
1.2.1 Molecular Dynamics 
 MD is a computational simulation technique that is a useful tool in understanding 
small-scale biological and other systems in atomistic detail. In MD, atomistic trajectories 
are constructed based on Newton’s laws of motion.
16
 That is, an atom with mass m that is 
subject to a force Fi will move based on the relationship: 
    




                                                                      
with the force and position (xi) in the i=x,y,z directions. Thus, through a Taylor series 
expansion, the positions of any atom in this system can be calculated between any time t 
and any time t0+t by knowing the forces acting on the atom as well as the initial position 
and velocity of the atom at time t0. By repeating this procedure, a trajectory can be 
formed that displays the positions of all atoms in a system over some course of time. Of 
course, this approach requires the initial positions and velocities of all atoms in the 
system to be known. Positional data is typically acquired from experimental data (for 
example, the x-ray crystallographic coordinates of the Osh4 protein simulated in Section 
2.3) or from a theoretical model (for example, the construction of the yeast membrane 
system discussed in Section 3.2). Initial velocities must be assigned, and are typically 
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done so by applying a random number generator to the Maxwell-Boltzmann distribution 
at the temperature of interest.
16
 
 Forces or energies are calculated through evaluation of a potential energy 
function, termed a ‘force field’ which consists of bonded and non-bonded interaction 
parameters. The form of the CHARMM force field
17
 is shown in Equation 1.2: 
               
 
     
          
 
      
           
 
            
                 
         
          
 
         
      
     
   
   
   
 
  
   
   
   




    
      
 
          
     
                                                                                                    
        
 
Internal terms (bond length (b), valence angle (), dihedral angle (), improper dihedral 
angle (), and Urey-Bradley (S)) are approximated as harmonic, with the exception of the 
dihedral. The terms b0, θ0, and ω0 refer to the equilibrium bond length, angle, and 
dihedral angle respectively. S0 is the Urey-Bradley equilibrium term and n and δ refer to 
the multiplicity and phase in the dihedral and φ represents the dihedral angle. Non-
bonded terms account for Lennard-Jones interactions and electrostatic interactions. The 
terms εmin and Rmin represent the well depth and radius of the Lennard-Jones term with rij 
representing the distance between atoms i and j. The term qi and qj represent the partial 
charges on atoms i and j. The term ε is the effective dielectric constant. Kb, Kθ, KUB, Kφ, 
and Kω are constants. The CMAP correction  is a 2D-energy correction term for the 






 Docking techniques are generally used to predict the structure of a complex 
formed when a ligand molecule binds to a receptor. Thus, it is imperative to sample a 
wide range of possible conformations in rapid succession. These techniques have also 
been used to identify potential binding sites along a protein’s surface when the binding 
location of a ligand is unknown.
18
 Docking is achieved by rotating and translating a 
ligand about the receptor. While the receptor conformation is typically held rigid, the 
ligand is often set to have rotatable bonds in order to increase the conformational 
sampling space. While flexibility of protein side chains can be achieved in many docking 
suites, the added degrees of freedom dramatically increase computational time.  
 Conformations that are produced during docking tests are evaluated against a 
scoring function in order to compare how well the predicted complex performs against 
other predicted complexes. A search algorithm, such as simulated annealing
19
 or a genetic 
algorithm
20
, uses information produced by the scoring function evaluation to generate a 
new set of conformations to test. There are many docking programs available, and each 
has a unique scoring function. The AutoDock4 scoring function,
21
 which was used for 
these tests, uses a free energy approach that compares the energy of the ligand and 
receptor separated with the energy of the ligand and receptor in complex (Equation 1.3)
21
: 
          
            
            
            
    
        
            
                                                                                
The entropic term (Sconf) in Equation 1.3 is estimated by multiplying the torsional degrees 
of freedom in the ligand by an empirically derived constant. The energy (U) contains a 
Lennard-Jones term, an electrostatics term, a hydrogen bonding term, and a desolvation 
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term based on the atomic solvation parameter (ASP) implicit solvation model (Equation 
1.4). Each term contains an empirically derived weighting value. 
       
   
   
   
   
   
  
   
             
   
   
   
   
   
   
   
       
    
            
                  
     
      
   
                                                                    
The terms Aij and Bij are Lennard-Jones parameters taken from the AMBER
22
 forcefield. 
The terms Cij and Dij are designed to assign the proper maximum well depth for atoms 
undergoing hydrogen bonds with directionality E(t) where t is the hydrogen bond angle 
with respect to the ideal hydrogen bonding angle. In the desolvation term, S represents 
the solvation parameter and V is the estimated volume of desolvation. The term σ is an 






CHAPTER 2 – LIGAND BINDING OF THE OSH4 PROTEIN 
 
2.1 Introduction 
 Of the seven Osh proteins encoded within the yeast genome, Osh4 is the most 
highly expressed with an abundance of approximately 32,000 macromolecules per cell.
10
 
As of now, Osh4 is the only ORP whose crystal structure has been solved, with structures 
available for the protein complexed with cholesterol, ergosterol, and three 
hydroxycholesterols.
23
 Three crystal 
structures of an engineered ‘lidless’ variant 
are also available where the protein exists 
in an unliganded state with residues 1-29 
removed and the 236-240 surface loop 
replaced by an ectopic dipeptide sequence. 
Because MD and docking techniques 
require an initial coordinate set, Osh4 can 
be used with these techniques. For the 
liganded structures, sterols bind inside of a 
tunnel formed by a 19 strand -sheet that 
nearly forms a complete -barrel (Figure 
2.1). A flexible N-terminal lid domain 
occludes the bound sterol from the aqueous 
phase. Recently, it has been suggested that 
Figure 2.1 – The structure of the Osh4 protein  
complexed with ergosterol and divided by sub-
domain . Protein regions are color coded as 
follows: lid region (residues 1-29) – red; central 
helices region (30-116) – orange; -barrel region 




the N-terminal lid forms an ArfGAP1 lipid packing sensor (ALPS) motif, a membrane 
binding motif that preferentially targets membranes with a high positive curvature (38 
versus 90 nm liposomes).
24
 This lid is thought to bind to membranes in the sterol free 
(apo) or open state, allowing for sterol uptake from the membrane. 
While the ALPS motif is not found on most ORPs, several ORPs contain other 
functional domains located in the N-terminus with respect to the ORD. For example, the 
Osh1-3 proteins as well as human OSBP and several other human ORPs contain a 
Plecstrin homology (PH) domain.
25
 Many, though not all, PH domains can bind PIPs with 
varying degrees of affinity.
26
 Though Osh4 lacks a PH domain, its ORD is capable of 
binding to PIPs.
27
 Furthermore, the presence of phosphatidylinositol(4,5)biphosphate 
(PIP2) has been shown to stimulate cholesterol transfer between donor and acceptor 
liposomes in vitro, and may possibly serve as means for the regulation of sterol 
distribution between cellular compartments by ORPs.
14
 Though the mechanism of 
interaction between PIPs and Osh4 remains unclear, it is thought that PIP binding occurs 
on regions of the external surface of the protein. A triple glutamate 
(R236E/K242E/K243E) Osh4 variant is incapable of binding to PIPs, while alterations to 
charged residues near the mouth of the sterol-binding pocket do not affect PIPs’ ability to 
stimulate sterol transfer between membranes, suggesting that the flexible 236-244 surface 
loop may be important with regards to Osh4’s ability to attach to PIP membranes.
27
 
However, due to the location of this loop away from the mouth of the Osh4 binding 




Previously, MD simulation has been used to investigate the Osh4 protein 
complexed with cholesterol in both Singh et al.
28
 and Canagarajah et al.
29
 In Singh et al., 
water-mediated interactions between the ring hydroxyl group of cholesterol and polar 
residues in the Osh4 binding pocket were found to be significant for sterol binding, while 
the lid had a negligible effect on stabilizing the bound sterol within the binding pocket. 
Additionally, a mechanism for sterol release and uptake from the cytoplasm was derived 
and conceptualized as a dual molecular ladder.
28
 Stepwise cholesterol unbinding was 
also observed in Canagarajah et al.
29
 where the rate limiting step in sterol exchange was 
identified as the lid opening event. In Canagarajah et al., the Osh4 7 helix was suggested 
to exist in a mobile, meta-stable state while the lid was closed and suggested to exist in a 
lower mobility, stable state in the apo conformation.
29
 
The studies presented within this chapter aim to further investigate the energetics 
of sterol binding through MD simulations of the Osh4 protein complexed with yeast’s 
natural sterol, ergosterol. Region specific backbone structural changes of the Osh4 
protein are also examined over the course of these simulations in order to identify 
conformations not observable in the crystal structure. In addition, docking studies are 
used to probe the protein surface for regions that have affinity towards certain 
phospholipids that are either commonly found in yeast membranes or stimulate Osh4 
mediated sterol transfer in vitro: phosphatidylcholine (PC), phosphatidylserine (PS), 
phosphatidylinositol(4,5)biphosphate (PIP2), and phosphatidylinositol(3,4,5)triphosphate 
(PIP3). The goal of this work is to better understand how the Osh4 protein binds to 
sterols. The docking studies with model lipid head groups will be useful for identifying 
potential membrane lipid attachment sites. This will, in turn, provide a better 
13 
 
understanding of how this protein, as well as similar human proteins with high sequential 
homology, attach to cellular membranes. This knowledge will be useful in ultimately 
understanding the mechanism to which this protein, and similar proteins, transfer 
biological sterols between intracellular membranes. 
2.2 MD Simulation of Ergosterol in Solvent 
2.2.1 Methods 
Two MD simulations were conducted: One with ergosterol solvated in water and 
one with ergosterol solvated in ethanol. Water (TIP3P)
30
 was selected as it is the primary 
constituent of cytosol and ethanol was selected in order model the experimental setup for 
the ligand binding assay experiments presented in Im et al.
23
 For both simulations, 
ergosterol was placed at the center of a cubic box consisting of pre-equilibrated solvent. 
This was followed by 100 steps of steepest descent (SD) minimization and 1,000 steps of 
Adopted Basis Newton-Rhapson (ABNR) minimization in order to reduce unfavorable 
energy contacts. Both simulations were then heated from 110.15 K to 310.15 K over a 
period of 100 ps in CHARMM
17
 using a 1-fs timestep. This was followed by 11 ns of 
constant pressure, temperature, and molecular (NPT) dynamics in CHARMM, of which, 
the last 10 ns were used for data collection purposes. Pressure was held constant at 1.0 
bar using a Langevin piston and the temperature was held constant at 310.15K using the 
Hoover thermostat.
31
 Lennard-Jones interactions were smoothed by a switching function 
over the 8-12 Å range and Particle Mesh Ewald (PME)
32
 was used to compute long range 
electrostatics. All hydrogen atoms were constrained using the SHAKE algorithm.
33
 Both 
systems used cubic periodic boundary conditions. The CHARMM C22
34
 force field was 
14 
 
used for both simulations. Ergosterol was parameterized using existing cholesterol 
parameters
35
 as a reference.  
The ethanol solvent was prepared by creating a cubic lattice of randomly rotated 
ethanol residues. This was minimized with 1,000 steps SD and 1,000 steps ABNR 
minimization and then heated in CHARMM for 100 ps using a 1-fs timestep up to 310.15 
K. This was followed by 2 ns of NPT MD simulation in CHARMM in a manner 
consistent with the ergosterol-ethanol simulation described above.   
The ergosterol/water simulation system consisted of one ergosterol residue and 
1,780 water molecules for a total size of 5,413 atoms. The ergosterol/ethanol simulation 
system consisted of one ergosterol residue and 1,714 ethanol residues for a total system 
size of 15,499 atoms.  
2.2.2 Results 
The interaction energy between ergosterol and solvent was calculated for both the 
water and ethanol simulations using CHARMM routines (Table 2.1). Ergosterol posses a 
higher affinity (2.53 kcal/mol) towards ethanol than water due to a higher contribution 
from the van der Waals (vdW) interactions between the nonpolar alkane portion of 
ethanol with the hydrophobic portion of ergosterol. The total interaction energy is further 




Water -45.34 ± 0.37 -22.39 ± 6.54 -7.86 ± 3.73
Ethanol -47.87 ± 0.76 -29.40 ± 7.48 -4.50 ± 3.37
Total (kcal/mol) vdW (kcal/mol) Electrostatics (kcal/mol)
 
 
Table 2.1 – Interaction energy between ergosterol and solvent. The total interaction energy, as well as 
the vdW and electrostatic contributions to the total are shown. 
15 
 
2.3 MD Simulation of Osh4 in Solvent 
2.3.1 Methods 
A total of five MD simulations were completed on the Osh4 protein complexed 




 packages. The initial x-ray 
crystallographic structure for this protein (PDB code 1ZHZ) as well as the residue 
numbering scheme is taken from Im et al.
23
 All waters contained in the crystal structure, 
as well as the liganded ergosterol residue, are maintained while the two Pb
2+
 ions were 
deleted. The third residue found in the crystal structure (P1) is referred to here as the first 
residue even though the initial crystal structure taken from the PDB contains two 
additional residues (M-1 and D0). These residues are not present in vivo. Appropriate 
CHARMM patches were applied to the N-terminal and C-terminal residues. The 
CHARMM C22 force field with CMAP correction
34; 37
 was used for these simulations, 
with ergosterol parameters and partial atomic charges conserved from the MD 
simulations of ergosterol in solvent. 
The protein was initially solvated in a pre-equilibrated TIP3P
30
 water box using 
CHARMM, forming a 100×100×100 Å cubic unit cell. Minimization was conducted in 
CHARMM using 100 steps of SD minimization followed by 1,000 steps of ABNR 
minimization in order to reduce unfavorable energy contacts. The initial -10 charge on 
the protein was neutralized in CHARMM using a 0.15 M NaCl solution. This was 
followed by an additional 100 steps of SD and 100 steps of ABNR minimization. The 
system was heated in CHARMM from 110.15 K to 310.15 K over a period of 100 ps 
using a 1-fs integrator time step. The final temperature, 310.15 K, was selected for easy 
comparison with the Osh4-cholesterol simulations presented in Singh et al.
28
 From this 
16 
 
initial starting point, five production runs were conducted in NAMD by varying the initial 
velocity seeds. Each production run was allowed to thermally equilibrate for a period of 
500 ps using a 2-fs integrator time step. During this equilibration period, pressure was 
held constant at 1.0 bar using a Langevin piston and the temperature was rescaled ever 
500 timesteps. Following equilibration, 25 ns of constant pressure, temperature, and 
molecular (NPT) simulation was completed. Pressure was maintained at 1.0 bar using a 
Langevin piston and the temperature was maintained at 310.15 K using Langevin 
dynamics. Lennard-Jones interactions were smoothed by a switching function over the 
10-12 Å range and PME
32
 was used to compute long range electrostatic potentials. 
Periodic boundary conditions were used and all hydrogen atoms were constrained using 
the SHAKE algorithm
33
 in CHARMM or the RATTLE algorithm
38
 in NAMD. 
The solvated Osh4 system consisted of 1 protein, 1 ergosterol residue, 34 chlorine 
ions, 44 sodium ions, and 29,715 water molecules for a total system size 96,419 atoms. A 
combined total of 0.25 s was sampled across all production runs. 
2.3.2 Results 
The structure of the Osh4 protein did not deviate dramatically during the course 
of any of the 25-ns simulations, as indicated by the root mean square displacement 
(RMSD) of the Osh4 C-C backbone atoms with respect to the x-ray crystallographic 
structure. Of the five production runs conducted, all RMSD values fell within the range 
of 1.00-3.29 Å with an average RMSD of 2.09±0.26 Å over the final 10 ns of simulation 
(Figure 2.2). These RMSD values indicate that Osh4 is structurally stable throughout the 
course of all simulations. 
17 
 
Lid Last 10 ns of simulation
Run Min Max Avg Std
1 0.41 6.87 5.43 0.81
2 0.71 4.07 1.66 0.09
3 0.82 3.95 2.33 0.50
4 0.51 3.34 1.92 0.34
5 1.06 3.15 1.92 0.22
Central Helices Last 10 ns of simulation
Run Min Max Avg Std
1 0.62 1.54 1.11 0.05
2 0.69 1.65 1.15 0.06
3 0.71 1.64 1.13 0.09
4 0.72 1.54 1.06 0.09
5 0.72 1.53 1.13 0.08
Beta Barrel Last 10 ns of simulation
Run Min Max Avg Std
1 0.92 1.70 1.23 0.09
2 0.86 1.63 1.30 0.07
3 0.82 2.47 2.09 0.07
4 0.82 1.84 1.48 0.10
5 0.80 1.94 1.52 0.15
C-terminus Last 10 ns of simulation
Run Min Max Avg Std
1 0.92 3.28 1.79 0.29
2 0.72 5.36 3.50 1.07
3 0.76 3.47 1.96 0.47
4 0.84 2.59 1.50 0.27
5 0.71 3.06 1.50 0.34
 
Figure 2.2 – RMSD vs. time for five 
Osh4/ergosterol MD simulations. All trajectories 
are shown separately. 
Table 2.2 – RMSD of the Osh4 protein for all 
production runs. Minimum and maximum values 
are calculated from the full 25-ns trajectories 
while averages  (Avg) and standard errors (Std) 




In order to determine which 
regions of the protein contributed most to 
any structural deviations from the x-ray 
crystal structure, the RMSD of carbon 
backbone atoms in each sub-domain was 
also investigated. Sub-domains were 
divided in the same manner as in Im et 
al.
23
 and are displayed in Figure 2.1. For 
all simulations, the structure of the -
barrel sub-domain does not deviate 
substantially from the x-ray crystal 
structure (Table 2.2). The lid sub-domain typically showed the widest range of RMSD 
values for all simulations. Particularly high RMSD values were observed during one 
trajectory, MD1 (Table 2.2), where the lid RMSD drastically increased after 
approximately 12 ns and eventually reaching a plateau of ~6 Å during the last 5 ns of 
simulation (Figure 2.3). Though the orientation of the 1 helix (residues 9-21) remained 
stable during the course of these simulations, the first 6 residues or the N-terminus were 
found to be flexible and are responsible for the wide variation of RMSD values observed 
for the lid sub-domain. The flexibility of these residues has also been observed in an MD 
study of the Osh4 protein complexed with cholesterol by Singh et al.
28
 The C-terminal 
sub-domain also showed a wide variability in RMSD when compared with the central 
helices and -barrel sub-domains. Conformational changes on a large, surface loop 
consisting of residues 367-381 between the 18 sheet and the 8 helix largely account for 
Figure 2.3 – RMSD vs. time for the MD1 
simulation run of Osh4 complexed with 
ergosterol. Sub-domains are shown in Figure 2.1. 
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the observed variability in RMSD for this region. A range of RMSD values between 0.30 
and 4.30 Å was encountered within this loop region. Binning of RMSD data indicates 
that this loop can exist in a multitude of conformations, even across the short timescales 
presented by this study (Figure 2.4).  
The RMSD of a surface loop consisting of residues 236-244 was also investigated 
as this loop is thought to be potentially important with regards to membrane 
attachment.
27; 39
 This loop was found in multiple conformations throughout the course of 
these simulations. Most conformational changes in this loop occurred on the order of 
picoseconds and were usually characterized by an RMSD change in the loop of ~1 Å 
followed by a several nanosecond plateau at a new value, though several intermediate 
conformations existed that lasted on the order of tens to hundreds of picoseconds (Figure 
Figure 2.4 – Conformational probability of the 
367-381 loop. RMSD data is binned by 0.1 Å and 
is collected over the entire course of all 25-ns 
simulations. 
Figure 2.5 – RMSD vs. time for the 236-244 
surface loop taken from the MD3 simulation run. 
Snapshots of this loop from this trajectory is 
shown in Figure 2.6. 
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2.5). Generally, two stable conformations for this loop were encountered: a folded 
conformation where the loop is folded upon itself and an extended conformation (Figure 
2.6). The folded conformation was present in the proteins crystal structure. Several 
hydrogen bonds stabilize this conformation, including S234-S240, S245-S240, and G235-
G241 backbone hydrogen bonds. A backbone hydrogen bond between Y238 and G241 
was also found in this conformation, though was not as commonly encountered as the 
other hydrogen bonds. A hydrogen bond between the R236 side chain and the G241 
backbone was also encountered. In the extended conformation, most of the stabilizing 
hydrogen bonds found in the folded conformation are broken. The Y238-G241 backbone 
hydrogen bond remains present and is more frequently encountered, and an S245-K242 
Figure 2.6 – Two stable conformations of the 236-244 surface loop. A, The backbone atoms of the loop 
are kinked so the tip runs parallel to the Osh4 surface (folded conformation). Backbone hydrogen bonds 
between S234-S240, S245-S240 and G235-G241 are shown. Y238-G241 backbone hydrogen bonds are 
found in this conformation, but are not shown. B, The backbone atoms of the loop adopt a more 
extended conformation that is more perpendicular to the Osh4 surface (extended conformation). 
Backbone hydrogen bonds between S245-K242 and Y238-G241 are shown. All hydrogen atoms were 
included in each simulation, though some are not displayed here. 
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backbone hydrogen bond is formed. Larger RMSD values for this region agree with the 
elevated mobility observed in MD simulations of Osh4 complexed with cholesterol in 
Canagarajah et al.
29
 and agree with higher than average B-factors found in this region of 
the crystal structure.  
The binding energies (ΔE
bind
) of ergosterol was calculated using CHARMM 
routines for each simulation and then averaged. The ΔE
bind 
of ergosterol was found to be -
61.10±1.26 kcal/mol, with vdW interactions contributing greater than electrostatics to the 
total binding energy. 83% of the total ΔE
bind 
was attributed to vdW interactions. The 
average binding energy relative to the solvation energy (ΔE
bind/sol
) for ergosterol was also 
calculated in a manner consistent with Singh et al. (Equation 2.1):
28
  
                                                                                   





respectively) are reported in Table 2.1. From Equation 3.1, ΔΔE
bind/sol-wat
 is found to be    
-15.75 kcal/mol while ΔΔE
bind/sol-eth
 is found to be -13.23 kcal/mol. It is important to note 
that these binding energy calculations ignore any entropic contributions to the free 
energy, and rather provide an estimation of the enthalpic term. However, based on these 
energy calculations, it can be seen that Osh4’s affinity towards ergosterol is similar in 
both a physiological water environment and the ethanol environment used for the binding 
affinity experiments presented in Im et al.
23
 
Residue specific ergosterol-protein interaction energies were calculated using 
CHARMM routines and are shown in Table 2.3, where they are compared with the 
interaction energy data presented for cholesterol complexed to Osh4 taken from Singh et 
al.
28
 Comparisons with the Osh4 protein complexed to 25-hydroxycholesterol are 
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presented in Rogaski et al.
40
 Nonpolar residues 
in the Osh4 binding tunnel showed similar 
interaction energies when compared with those 
of cholesterol for most cases. However, some 
anomalies existed due to the structural 
differences between ergosterol and cholesterol 
(Chapter 1, Figure 1.1). Interactions between 
the cholesterol and ergosterol tails with charged 
residues near the mouth of the binding pocket 
(E107 and K108) varied significantly. 
Backbone atoms in K108 and K109 form vdW 
interactions on one side of each sterol’s tail 
while hydrophobic residues (L241, L177, and 
I203) form vdW interactions with the other side 
of the tail. The E107 side chain is positioned 
near the five membered sterol ring, and also 
displayed significant variation in terms of 
interaction with ergosterol versus interaction 
with cholesterol. As the positioning of the 
ergosterol tail did not change significantly 
during the course of MD simulation, the 
marked differences in interaction energy for 
L24, E107, and K108 when compared with 
Nonpolar
residues
F13 -0.7 +/- 0.1 -0.9 +/- 0.7
L24 -1.2 +/- 0.2 -2.2 +/- 0.4
L27 -0.4 +/- 0.2 -0.7 +/- 0.2
I33 -1.2 +/- 0.1 -1.0 +/- 0.1
L39 -1.9 +/- 0.1 -2.0 +/- 0.2
F42 -4.0 +/- 0.2 -4.1 +/- 0.3
P110 -1.9 +/- 0.1 -2.2 +/- 0.2  
I167 -1.8 +/- 0.1 -2.4 +/- 0.1
L177 -1.4 +/- 0.3 -1.1 +/- 0.2
V179 -1.1 +/- 0.2 -1.0 +/- 0.2
L201 -1.4 +/- 0.1 -1.6 +/- 0.2
I203 -2.3 +/- 0.2 -2.6 +/- 0.3
I206 -1.1 +/- 0.2 -1.0 +/- 0.2
P211 -1.0 +/- 0.1 -0.9 +/- 0.1
V213 -0.8 +/- 0.2 -1.1 +/- 0.1
Polar
W46 -1.0 +/- 0.5 -1.1 +/- 0.5
Q96 -4.9 +/- 1.3 -4.5 +/- 0.9
Y97 -3.1 +/- 0.2 -3.9 +/- 0.3
N165 -2.1 +/- 0.3 -2.1 +/- 0.5
Q181 -2.1 +/- 0.3 -2.7 +/- 0.5
Charged
residues
E107 -4.0 +/- 0.2 -5.1 +/- 0.2
K108 -2.4 +/- 0.2 -1.1 +/-  0.2





Table 2.3 – Averaged interaction energies 
between sterols and significant nearby 
residues. Most cholesterol data is taken from 
Singh et al., where electrostatics are not 
included in the interaction energies for 
nonpolar residues. Residues in italics were 
provided from the authors of Singh et al., and 




cholesterol can be explained by the differences in structure and composition of each 
sterol’s respective tail. 
Of the polar residues situated at the bottom of the binding pocket, Q96 displayed 
the most favorable interaction energy with ergosterol. Additionally, this residue displayed 
the most favorable electrostatic interaction energy contribution (-2.4 kcal/mol). For all 
MD simulations conducted, the block-average computed standard error of the interaction 
energy between Q96 and ergosterol was also significantly higher than those reported for 
other residues. Interaction energy data for Q96 over all five simulations was combined 
and binned by 0.1 kcal/mol intervals. Through binning, Q96 displayed two distinct 
energetic peaks separated by approximately 5 kcal/mol, which is shown in Figure 2.7. 
The binned Q96 interaction energy data was fitted to multiple (4) Gaussian distributions 
in order to estimate the total probability associated with each dominant peak. By 
integrating all Gaussian fits associated with each energy state, it was found that the lower 
energy state was encountered 21% of the time over all ergosterol simulations while the 
higher energy state was encountered 79% of the time over all simulations. The maximum 
frequency for the lower and higher energy states from the interaction energy histogram 
were -9.2 kcal/mol and -4.1 kcal/mol, respectively. The lower energy peak is attributed to 
direct hydrogen bonding between Q96 and ergosterol’s hydroxyl group while the higher 
energy peak is attributed to non-hydrogen bonded configurations or water-mediated 
hydrogen bonded configurations. Samples of observed binding configurations taken from 
MD simulation are shown in Figure 2.8.  
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A similar analysis was conducted on all other residues displaying significant 
interaction with ergosterol, and no other residue exhibited the same two peak pattern as 
Q96. However, the interaction energy of W46 displayed a highly skewed distribution 
(Figure 2.7) that may possibly contain a small peak obscured under the tail of a much 
larger peak. On occasion, polar atoms on W46 did come in close enough contact with the 
ergosterol hydroxyl group to form direct hydrogen bonds, but generally for only a short 
duration. Any direct hydrogen bonding between ergosterol and W46 appears to be 
unstable. 







Figure 2.8 – Sample binding conformations of ergosterol with Osh4. A, Ergosterol forming a direct 
hydrogen bond with W46 as well as a water-mediated hydrogen bond with Q181. B, Ergosterol forming a 
direct hydrogen bond with Q96. C, Ergosterol forming a water-mediated hydrogen bond with Q96. D, 
Ergosterol forming multiple water-mediated hydrogen bonds with W46, Q96, and Q181. Nonpolar 
hydrogens were simulated, but are not shown. Hydrogen bonds are shown as dashed lines. 
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2.4 Docking of Model Lipid Head Groups to the Osh4 Surface 
2.4.1 Methods 
Four model head groups were chosen for blind docking against the Osh4 surface, 
PC, PS, PIP2, and PIP3. The two inositol lipids, PIP2 and PIP3, were chosen because their 
presence within a membrane has been shown to increase sterol transport between donor 
and acceptor vesicles in vitro.
14
 PS was also chosen because increased PS concentration 
within a membrane has been correlated to an increase of sterol transfer between donor 
and acceptor liposomes in vitro, while 
also being enriched in the yeast plasma 
membrane (PM) in vivo.
39; 41
 PC was 
selected because it is enriched in the yeast 
endoplasmic reticulum (ER) in vivo.
41
 
Model head groups were constructed by 
truncating existing lipid coordinate files at 
the C2 carbon (Figure 2.9). Coordinates 




(POPS) coordinates taken from an MD 
simulation of a model yeast membrane 
(Chapter 3). Coordinates for PIP2 and PIP3 
were similarly derived from their 
Figure 2.9 – Structures of the four model lipid 




corresponding structures as presented in Li et al.
42
 For better sampling of protein 
structural conformations and side chain positioning, 5 snapshots were taken across 5-ns 
intervals from the MD1 and MD2 trajectories from the MD simulations of ergosterol 
complexed with Osh4. Two trajectories from MD simulations of Osh4 complexed with 
25-hydroxycholesterol that were conducted by Joseph Lim and presented in Rogaski et 
al.
40
 were also sampled across 5-ns intervals, as well as the crystal structure of Osh4 
bound to ergosterol and the crystal structure of Osh4 bound to 25-hydroxycholesterol for 
a total of 22 conformational snapshots. All bound sterol moieties and solvent molecules 
were removed prior to docking. Additionally, each ligand was docked against the crystal 






 chargers were applied to each model ligand in 
AutoDockTools4 (ADT4),
44
 and non-integral charges were manually adjusted in order to 
maintain the proper charge associated with each phosphate group. Protein atomic partial 
charges were conserved from the MD simulations used to produce the coordinates. 
Ligand bonds were allowed to be freely rotatable, but receptor bonds were held rigid. All 
docking tests used the Lamarckian Genetic Algorithm
20
 for searching and the default 
AutoDock4 (AD4)
44
 parameter set was used. The surface of the protein was searched 
using a 120×120×120 point grid with a grid spacing of 0.625 Å. Each conformational 
snapshot was docked 25 times for twenty-five million iterations per instance for each 
ligand studied, producing a total of 550 results. Each engineered lidless conformation was 




For each model compound tested, docking results for all conformations were 
pooled and the twenty conformations pertaining to the lowest AD4 free energy of binding 
(G
bind
) were selected for further analysis. These conformations are referred to as the ‘top 
results’. Because multiple receptor conformations were sampled for each model 
compound, clustering results by RMSD is not an ideal way to detect different binding 
sites using these tests. Instead, potential binding regions are segregated based on similar 
interacting residues. All results from the native Osh4 structures are pooled separately 
from the engineered lidless results. 
Docking with select flexible side chains was conducted on two regions of the 
protein using the PIP2 model ligand. The first region was identified by an area of the 
Osh4 surface that showed the highest tendency to dock model lipids in the blind docking 
tests. This region was confined by a 100×100×100 point grid with a grid spacing of 0.375 
Å, and was centered near the surface residue K180. As AD4 has a limit of 32 freely 
rotatable bonds for any given system, only select basic residues (K168, K180, K407, and 
K411) were set to have freely rotatable side chains. These residues had the highest 
tendency to interact with model ligands during the blind docking tests. The protein 
conformation most favorable towards PIP interaction during the blind docking tests was 
chosen as the receptor, and the PIP2 model was docked to this conformation 400 times 
with 2.5 million iterations per instance. Docked conformations were ranked by G
bind
 and 
the top 40 conformations were chosen as the ‘top results’.  
Two docked conformations from the top results were selected for MD testing to 
ensure the stability of the docked conformation. Coordinates from these two 
conformations were input into CHARMM, where hydrogens were built. Protein atoms 
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were then fully constrained while the PIP2 model was subject to SD and ABNR 
minimization. The structure was then solvated in a 100×100×100 Å TIP3P
30
 water box 
and neutralized with a 0.15 M NaCl solution in CHARMM. This structure was 
equilibrated for 100 ps in NAMD at 310.15 K using a 2-fs integrator timesetep. 
Temperature was rescaled every 500 timesteps, and pressure was held constant at 1.0 bar 
using a Langevin piston. Equilibrated structures were subject to a production run of 500 
ps in NAMD in the NPT ensemble where pressure was maintained at 1.0 bar using a 
Langevin piston and the temperature was maintained at 310.15 K using Langevin 
dynamics. Lennard-Jones interactions were smoothed over the 10-12 Å range and PME
32
 
was used for long range electrostatics. Periodic boundary conditions were used, and 
hydrogens were constrained using the RATTLE algorithm.
38
 
The second region analyzed by flexible residue docking was created by defining a 
sample space surrounding the 236-244 surface loop with a 100×122×100 point grid with 
a grid spacing of 0.375 Å centered about the center of the loop. All appropriate side 
chains (R236, Y238, F239, S240, K242, and N244) contained in the loop were set as 
freely rotatable bonds. Two protein conformational snapshots were used that pertained to 
the folded and extended conformations observed in this loop during MD simulation. PIP2 
was docked to each conformation 400 times with 2.5 million iterations per instance. 
Docked conformations were ranked by G
bind
 and the best 40 results were selected as the 







Of the model lipid compounds tested, the PC model presented the greatest 
diversity in terms of total number of binding sites identified in the top selected results. 
For this model, four different binding regions (Figure 2.10) were identified when docked 
against the crystal and MD snapshot conformations (Table 2.4). Two of these regions 
were also identified during the PIP2 tests while only one of these regions was found 
during the PIP3 and PS tests (Table 2.4). All regions identified during the PS, PIP2, and 
PIP3 tests were also identified during PC blind docking tests. High negative charges 
associated with the PIP models (-4 for PIP2 and -6 for PIP3) prevented docking to PC 
sites where near equal distributions of positively and negatively charged amino acids 
were encountered. This reduced the number of docked regions identified in PIP models 
compared to the PC model. However, given the electroneutrality of the PC model and its 
small size, nearly 50% of the results had to be rejected due to docking inside of the sterol 
binding pocket of the Osh4 protein. The docking of model lipids to within the sterol 
binding pocket occurred as a result of a vacant sterol binding pocket. This issue was more 
prevalent in conformations taken from MD snapshots of Osh4 complexed with 25-
hydroxycholesterol than in conformations taken from Osh4 complexed with ergosterol. 
There were no instances of either of the PIP models docking inside of the Osh4 sterol 
binding pocket during these tests and instances where PS docked inside of the pocket 
were rare. 
The five trajectories from the MD simulations of Osh4 complexed with ergosterol 
and the five trajectories from the MD simulations of Osh4 complexed with 25-





Figure 2.10 - Typical binding sites encountered by docking the PC model against the native Osh4 protein. 
A, A surface representation of the -crease region (left) is shown in orange with select residues labeled. 
The opposite side of the protein is shown (right) with the 3 region in red, the C-terminus region in yellow, 
and the 4-6 region in green. B, Representation of the -crease region (left) displaying Osh4 secondary 
structure with interacting residues found in the -crease site displayed as spheres positioned at the C 
carbons. The 3, C-terminus, and 4-6 regions are shown on the opposite side of the protein. Residues 
found experimentally to be important to membrane binding from Schulz et al. are labeled and displayed as 
purple (front binding surface), pink (distal binding surface), and cyan (neither front nor distal) spheres. 
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E51, E55, E66, H67, C68, L69, A84, K87
W426, D427, E429, K430, V433, L434





D21, G22, D23, L24, P145, Q166, K168, A169
A398, P399, G401, T402, L403, E408, K411
P36, K108, Y318, A321, K325
E412, D413, L414, S415
PIP2
-crease -4.06
Y45, S95, S99, R100, S103, L104, K108, K325
T178, K180, F182, P200, H202, E216, G217
F20, G22, P145, Q166, I167, K168, A169, S170
P399, S400, T402, D406, K407, E408, K411
K180, F182, H202, E216, G217, K218, Y220
K258, P399, S400, G401, T402, L403, D406
F20, D23, K168, A169, S170, T172, K173, T178
K407, E408, K411
-2.47
K218, Y220, G237, Y238, F239, K258, A398
-4.73
G401, T402, L403, D406, K407, E408, K411, L414
G22, D23, L24, S25, H143, H144, P145, P146
Q166, I167, K168, A169, S170, T178, K180
G237, Y238, F239, S240, N397, P399, S400
Q181, F182, P200, G217, K218, E232, S234
were analyzed using the program HOLE,
45
 which measures the diameter of a pore within 
a macromolecule along a vector that runs from the bottom of the binding pocket towards 
the opening created by removal of the lid residues . Because the binding pocket of Osh4 
is fully enclosed, the lid residues were deleted for this analysis. The average size of the 
Osh4 binding pocket was nearly identical for both sterol ligands (Figure 2.11). Therefore, 
the increased likelihood for Osh4/25-hydroxycholesterol to accept small model 
compounds within the binding pocket when compared to Osh4/ergosterol is most likely 
caused by the side chain positioning at the instants when the snapshots were taken. 
Table 2.4 - Osh4 residues found to interact with docked ligands for rigid receptor tests. Only 
conformations found in the top results are shown and factored into the average binding energies. Average 
energies denoted with an asterisk only contained one conformation in the top results. 
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The four binding regions identified 
for the PC model are color-coded in 
Figure 2.10. Among all of the top results, 
the 3 region produced the conformation 
exhibiting the most favorable ΔG
bind
        
(-3.26 kcal/mol). However, only two out 
of the twenty selected results for this test 
were contained in this region. The 3 
region is located near the distal side of the 
protein, interacting with residues on the 
solvent exposed portion of the 3 and 4 
helices as well as the surface loop that 
connects them. Both conformations in this region were stabilized through electrostatic 
interactions between a glutamic acid residue (E51/E59) and the choline group of PC as 
well as electrostatic interactions between a lysine side chain (K87) and the phosphate 
group of PC (Figure 2.12A). Another PC binding site (C-terminus region) was stabilized 
through electrostatic interactions with residue types similar to those found in the 3 
region. This region was not frequently encountered during testing, constituting only one 
of the top results with a ΔG
bind
 of -2.49 kcal/mol (Figure 2.12B). Similarly, the 4-6 
region only constituted one of the top results with a ΔG
bind
 of -2.46 kcal/mol. Of these 
three sites, only the 4-6 region was also encountered when docking with PIP models. 
This region appeared during PIP2 tests but was only found in one of the top results for this 
model (-4.08 kcal/mol, Figure 2.12B) and did not appear in any of the PIP3 top results. 
Figure 2.11 – Pore radius of the Osh4 binding 
tunnel complexed to two distinct sterol ligands. 
Averages were computed over 25-ns MD 






Figure 2.12 - Sample binding conformations of PC, PIP2, and PIP3 model ligands. A, A sample 3 
conformation produced through rigid-receptor docking of PC (highlighted). B, C-terminus region 
conformation produced through rigid-receptor docking of PC (highlighted). C, An 6 region conformation 
produced through rigid-receptor docking of PIP2 (highlighted). D, A sample -crease region conformation 
produced through rigid-receptor docking of PIP3 (highlighted). Osh4 residues interacting with docked 
ligands are displayed and labeled. 
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The -crease region was located near the mouth of the sterol binding pocket, 
centered near K180, and was defined by a crease between a solvent accessible portion of 
the -barrel and a large surface loop towards the C-terminal end of the protein. This site 
was the most prevalent binding site encountered during blind docking tests of the native 
Osh4 protein surface for all model ligands, being encountered in 16 top results for PC     
(-2.88 kcal/mol, most favorable conformation), 19 cases for PIP2 (-4.86 kcal/mol, most 
favorable), and all 20 cases for PIP3 (-5.30 kcal/mol, most favorable) and PS (-5.22 
kcal/mol, most favorable). Though nearly all of the lowest energy PIP2 and PIP3 
conformations docked within this region, several receptor conformations taken from MD 
snapshots failed to dock PIP2 or PIP3 in this region favorably. For these snapshots, PIP2 
and PIP3 favored the 4-6 region. However, because ΔG
bind 
was typically unfavorable 
for the 4-6 region in most cases, the region is lowly populated in the top results for 
PIP2 (1 result out of 20) and unpopulated for PIP3. The RMSD analysis presented in 
Section 2.3.2 demonstrates that the -barrel, which partially defines the -crease region, 
does not structurally deviate significantly with respect to the protein’s crystal structure. 
An additional RMSD analysis on the second section partially defining the -
crease region, the 393-416 loop, also yielded no significant deviations from the protein’s 
crystal structure (RMSD < 1 Å).  Therefore, it is conjectured that specific side chain 
orientation is responsible for the favorability of some receptor conformations over others 
to the -crease site. Though all receptor conformations docked PS well, PS docked to 
different sites within the -crease region in a manner largely dependent on receptor 
conformation. Most results in this region were centered about K168 and/or K180 (Figure 
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2.13A) though two results were found 
closer to the 236-244 loop, stabilized by 
electrostatic interactions between K218 
and E232.    
Most results in this region were 
centered about K168 and/or K180 
(Figure 2.13A) though two results were 
found closer to the 236-244 loop, 
stabilized by electrostatic interactions 
between K218 and E232.    
Residues in the -crease region 
found to interact with PC, PS, and both 
PIP models during these docking studies 
are situated near several residues 
identified in Schulz et al.
39
 that may 
interact with liposomes (Figure 2.10B). 
K168 and K411 were frequently found to 
interact with all models used during 
docking tests, while E412C and A169C 
were two mutations that showed a high 
degree of cross-linking. The -crease 
region was also located near S174, a 
residue implicated in cysteine-replacement 
Figure 2.13 - Sample binding conformations of PS 
and PIP2 model ligands. A, Sample conformation 
produced through rigid-receptor docking of a PS 
model ligand is shown with PS highlighted. Osh4 
residues interacting with the docked ligand are 
displayed and labeled. B, Snapshot taken from 500-ps 
MD of PIP2 with Osh4 interacting residues displayed 
and PIP2 highlighted.  All hydrogen bonds are shown 
as dotted lines. Nonpolar hydrogens were simulated 
in the MD simulation, but are not shown. 
37 
 
studies. Docking results were generally encountered in close proximity with the Osh4 
‘front’ membrane interaction surface (as defined in Schulz et al.
39
) though no models 
used in these tests docked near the proposed distal binding surface to any significant 
degree, with the two cases where PC bound to the 4-6 region being the only exceptions 
(Figure 2.11B). It is important to note that PC binding energetics were heavily influenced 
by vdW contributions, suggesting that PC was biased towards more ‘pocket’ like regions 
of the protein. Therefore, it is unlikely that docking studies using a single PC molecule 
would be able to detect a large surface on the protein favorable towards interaction with a 
slab of multiple membrane lipids.  
The -crease region contains a high concentration of basic residues, which were 
often found to interact with multiple PIP phosphate groups. For PIP ligands, electrostatic 
interactions tended to dominate over other AD4 force field effects, though, given the 
creased shape of the pocket, other interaction terms (vdW, desolvation, and hydrogen 
bonding) were not insignificant. Though PIP2 conformations tended to interact with 
multiple lysine residues, only a small proportion of the results displayed conformations 
where each of the three phosphate groups was complexed with a lysine. Similarly, the 
maximum observed number of lysine-phosphate groups for PIP3 was three (Figure 
2.12D), and no instances where all PIP3 phosphates were complexed with lysines was 
encountered. PIP2 is believed to be the primary PIP species involved in the stimulation of 
sterol transport by Osh4 through in vitro experperimentation.
14 
Experimentally, it has 
been shown that a fragment of the Osh4 protein consisting of residues 171-314 is 
sufficient for PIP2 as well as inositol-1,4,5-trisphosphate (IP3) binding.
27
 PIP  ligands 
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docked almost exclusively to a region between residues 166-258 while also exhibiting 
interactions with a nearby region of the protein contained by residues 398-411.  
Blind docking using the crystal structure taken from the engineered lidless form 
of the Osh4 protein as the rigid receptor produced similar results when compared to 
docking against the full protein structure. PIP ligands favored the -crease region for all 
cases selected in the top results for two out of the three receptor conformations obtained 
from the available crystal structures (PDB codes 1ZI7A and 1ZI7C). The most 
energetically favorable conformations in this region were -5.11 and -6.38 kcal/mol for 
PIP2 and PIP3, respectively. However, for the third conformation studied (PDB code 
1ZI7B), results were exclusively encountered in a distinct region closer to the mouth of 
the sterol binding pocket characterized by electrostatic interactions with K109 and K336 
Ligand Cluster Interacting Residues Avg. Energy
P145, P146, Q166, K168, A169, S170, K180
K218, Y220, N397, P399, D406, K407, E408, K411   
mouth K109, P110, L111, N112, L177, I324, I332, K336 -4.64
P145, P146, I167, K168, A169, S170, T178
K180, F182, L201, K407, E408, K411
mouth K109, P110, L111, N112, I167, A169, W317, I324, K336 -3.57
K168, A169, S170, T178, K180, F182, L201, E216
G217, K218, Y220, S254, K255, N392, A398, L403
P404, K407, E408, K411, L414
mouth K109, P110, L111, N112, K336 -4.31*
E48, K94, S95, R100, E102, S103, K108










Table 2.5 - Osh4 residues found to interact with docked ligands for rigid receptor tests (apo 
conformation). Only conformations found in the top results are shown and factored into the average 




as well as vdW interactions with several nonpolar residues sequentially located near 
K109. The most energetically favorable conformations in this region were -5.30 kcal/mol 
for PIP2 and -3.88 kcal/mol for PIP3. Interacting residues identified in this region, denoted 
as the mouth region, are shown in Table 2.5 along with -crease region interacting 
residues also identified during the ‘engineered-lidless’ tests. The mouth region is not 
solvent accessible when the Osh4 lid remains intact.  
The -crease region was also commonly encountered in PS docking tests (-6.27 
kcal/mol, most favorable). PS demonstrated an ability to bind to the mouth region (-4.31 
kcal/mol, most favorable), a region near the entrance of the sterol binding tunnel, for one 
receptor conformation (PDB code 1ZI7B). PS models also docked to the 4-6 region 
encountered during PC/PIP2 tests against the native Osh4 protein. However, specific 
residues identified in the 4-6 region during the lidless tests tend to lie closer to the 4 
helix and away from the 6 helix due to conformational differences between the apo and 
native Osh4 structures. This area is denoted as the 4 region (Table 2.5). The PC ligand 
typically docked near the mouth of the binding tunnel, though most PC docked 
conformations tended to penetrate deeper into the binding pocket. PC docking in this 
region may be caused by the ligand’s preference towards the sterol binding pocket, an 
issue that was also encountered during blind docking tests against Osh4 in its native state 
caused by the absence of the bound sterol in receptor conformations. Due to the high 
occurrence of PC docking inside of the sterol binding pocket, PC results are not presented 
in Table 2.5. 
The -crease region was further investigated by allowing for select flexible side 
chains (K168, K180, K407 and K411). These residues were commonly found to interact 
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with PIP2 during blind docking tests. Surprisingly, although K168 was a common 
interacting residue identified in rigid tests, only a few docked conformations were 
identified in the top results that showed interaction with this residue. A range of ΔG
bind
 
from -10.7 to -9.21 kcal/mol was encountered in the top results for these tests. K180 was 
found to be the dominant interacting residue, stabilizing the bound conformation through 
electrostatic interactions with a PIP2 phosphate and was typically coordinated 
electrostatically with nearby K407 and/or K411. It should be noted that the calculated 
ΔG
bind
 was found to be significantly lower when using flexible residues on the protein. 
This is, in part, caused by an improvement of the protein’s intramolecular energetics 
when transitioning from the unbound to the bound state that is not present when the 
receptor is completely rigid.  
The stability of the binding conformations observed in this region was tested 
through a brief MD simulation. PIP2 did not unbind during 500-ps MD simulations of 
two select representative binding conformations in this region. However, specific lysine-
phosphate interactions displayed in the initial coordinates taken from the docked 
conformation were not always conserved. A sample conformation where PIP2 is 
interacting with three lysine residues is displayed in Figure 2.13B. Since backbone 
conformational changes upon binding are minimal during the timescales of these 
simulations, it is impossible to produce an exact schematic of the final PIP bound 
conformation. 
PIP2 docking with flexible protein side chains was also conducted on a sample 
space restricted to the 236-244 surface loop. Two representative conformations from the 
folded and extended conformations were analyzed with all side chains located within the 
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loop chosen to be freely rotatable. The top results from both conformations docked PIP2 
with similar affinities (ΔG
bind
 of -8.63 to -6.55 kcal/mol for the folded conformation and -
7.16 to -5.22 kcal/mol for the extended conformation) though neither conformation was 
able to dock PIP2 as well as the -crease region. However, energetic differences between 
docking to this site and the -crease region were typically small (1-2 kcal/mol). A wide 
variety of binding conformations existed for both the folded and extended states of the 
loop (Figure 2.14). A composite of the interacting residues identified within each region 
across all docking tests is shown in Figure 2.15. 
 
Figure 2.14 - Sample binding conformations of PIP2 to the 236-244 loop region with flexible side chains. 
A, A sample binding conformation produced through flexible side chain docking to the loop in its folded 
state. Hydrogen bonds between PIP2 and Y238/R236 are shown.  B, A sample binding conformation 
produced through flexible side chain docking to the loop in its extended state. Hydrogen bonds between 














Figure 2.15 - Lipid binding sites encountered on the Osh4 protein. The -crease region and mouth region 
(left) are shown in orange and blue, respectively. The opposite side of the protein (right) is shown with the 
3 region in red, the C-terminus region in yellow, and the 4-6 region shown in green. Regions are 
composed of residues encountered over all docking tests. 
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CHAPTER 3 – A MODEL YEAST MEMBRANE 
 
3.1 Introduction 
 Lipids are a diverse group of small hydrophobic or amphiphilic molecules that, 
generally, fulfill three basic biological functions. Firstly, some lipids such as steryl esters 
can be used as an efficient means of energy storage within the cell.
41
 Secondly, given the 
propensity for amphiphilic lipids to self associate in water, polar lipids form the basis of 
cellular membranes through the formation of, most notably, lipid bilayers.
41
  Thirdly, 
many lipids, such as PIP lipids, can act as signaling molecules for interaction with and 
recruitment of proteins.
41; 42
 The variations amongst lipid chains and lipid headgroups 
allows for a striking diversity in lipid types available within the cell. Moreover, different 
lipids are not homogeneously distributed across different organelles within the cell.
41
  In 
yeast, several dominant lipid types (divided by headgroup) exist. While a large majority 
of yeast membranes are comprised of PC, PS, PI, phosphatidylethanolamine (PE), and 
phosphatidic acid (PA) lipids, several other components such as cardiolipin and various 
glycolipids exist in small molecular concentrations.
46
  
 Up until recently, atomistic simulation of biological membranes typically 
consisted of only one or two types of phospholipids representing the dominant species of 
the membrane, along with some concentration of a sterol, typically cholesterol.
5; 47
 The 
introduction of the CHARMM-GUI Membrane Builder
48; 49
 provides an intuitive 
graphical user interface that allows for the web-based construction of membrane bilayers 
with support for over 32 lipid types and cholesterol. This aided in the first MD simulation 





study analyzed several key membrane properties, such as electron-density profiles and 
surface areas per lipid, of four model yeast membranes. Each membrane consisted of 
varying and distinct concentrations of six different lipid types using the CHARMM 
C27r
50; 51
 force field.  
 Previously, the CHARMM C27
52; 53
 and the revised C27r  force fields were used 
as the CHARMM parameter set to model membrane phospholipids. However, this force 
field possessed two notable flaws.
54
 The C27/C27r force fields produced a large positive 
surface tension that, consequentially, reduced the simulated surface area per lipid values 
to values below experimental estimates when simulated under zero surface tension to 
represent a flaccid bylayer. This causes a change in the phase of the membrane producing 
a near gel-like structure, even above the proper gel transition temperature. Secondly, 
experimental deuterium order parameters (SCD), which measures the order or disorder of 
C-H bond, demonstrate a splitting for the C2 carbon of the acyl chain (Figure 2.10 and 
Appendix) on many glycerophospholipids.
55
 This phenomena was not reproducible in 
MD simulation using the C27 and C27r force field.
54; 56
 The newly released CHARMM36 
(C36) force field,
54
 which contains several updates to the nonbonded and torsional 
parameters of lipid head group atoms, has been designed to obtain the correct surface 
area per lipid values when running in tensionless ensembles as well as provide for greatly 
improved modeling of SCD when compared to previous force fields. 
 The study presented within this section is concerned with testing the physical 
properties of a model yeast membrane through MD simulation. Unlike the model 
membrane systems presented in Jo et al.,
49
 this system contains ergosterol, the biological 
sterol that is present in yeast. Additionally, this simulation will utilize the newly 
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published C36 force field. Membrane properties such as the surface area per lipid, 
electron-density profile, aliphatic chain-ordering, and ergosterol tilt angle are analyzed. 
3.2 MD Simulation of a Model Yeast Membrane with Ergosterol 
3.2.1 Methods 
 An MD simulation of a model yeast membrane was conducted based off of the 
equilibrated coordinates of the CPR1 model yeast membrane presented in Jo et al.
49
 
This membrane was initially modeled after the average lipid content within the 
membranes of the CPR-1 strain of yeast, though phosphatidylinositol (PI) lipids were 
not considered as suitable CHARMM force-field parameters were not available. As the 
CPR1 model contains cholesterol, select coordinates from all cholesterol molecules 
within the lipid were deleted and rebuilt as the biologically relevant ergosterol residues 
using an internal coordinate table generated from MD simulation of ergosterol in water. 
The experimentally determined phospholipid head group concentrations and fatty acid 
compositions from Daum et al.
57
 are presented in Table 3.1, along with the membrane 
composition of the CPR1-ergosterol membrane used in this simulation. As the initial 
Unsat.
PA PS PC PE PI Other /Sat. ratio
Experimental Composition




9.5 4.8 57.1 28.6 0 0 9.5
6.7 3.3 47.8 20.4 16.2 5.6
Phospholipid Headgroup
Table 3.1 – Phospholipid composition of yeast membranes. The percentages of each head group are 
shown, as well as the ratio of unsaturated (unsat.) to saturated (sat.) fatty acid chains. 
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membrane structure has already been equilibrated, all non-ergosterol residues were fully 
constrained while ergosterol residues were subject to 1,000 steps of SD minimization 
followed by 2,000 steps of ABNR minimization in CHARMM.  
 The system was then equilibrated in NAMD for 500 ps using a 2-fs integrator 
time step. NAMD version 2.6 does not have the ability to mimic forced-based switching 
present in CHARMM. This produces a slightly higher attraction between residues and 
leads to a slight (1-2 Å
2
) decrease in surface areas per lipid when compared with 
CHARMM simulations.
55
 Pressure was held constant at 1.0 bar using a Langevin piston 
and the temperature was rescaled every 500 time steps. The surface tension was held at 
0.0 dyn/cm
2
. After equilibration, 60 ns of constant pressure, surface tension, temperature, 
and molecular (NPT) MD simulation was conducted in NAMD. Pressure was held at 1.0 
bar using a Langevin piston and Temperature was held at 303.15 K using Langevin 
dynamics. The surface tension was held at 0.0 dyn/cm
2
, which essentially leads to an 
NPT ensemble. Lennard-Jones interactions were smoothed over the 10-12 Å range and 
PME
32
 was used for long range electrostatics. A tetragonal unit cell was used where the x 
and y box lengths were constrained to be equivalent. Periodic boundary conditions were 
used, and hydrogen atoms were constrained using the RATTLE algorithm. After 40 ns of 
MD simulation, the average surface area per lipid reached a plateau value. Thus, all 
analysis within this section is completed on the trajectory within the 40-60 ns range. This 
MD simulation used C36 parameters
55
 for all lipids with the exception of ergosterol, 
which contained parameters and atomic partial charges consistent with all ergosterol 
simulations within Chapter 2. 
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 The model yeast membrane system consisted of two leaflets, with each leaflet 
containing 30 ergosterol residues, 50 DOPC residues, 5 POPS residues, 10 
dipalmitoylphosphatidylcholine (DPPC) residues, 10 palmitoyloleoylphosphatidylamine 
(POPA) residues, and 30 palmitoyloleoylphosphatidylethanolamine (POPE) residues. 
The system also contained 11,885 TIP3P water molecules, 46 potassium ions, and 16 
chlorine ions for a total system size of 67,587 atoms (Figure 3.1). The structures of 
individual phospholipids can be found in the Appendix section. 
3.2.2 Results 
In order to ensure that the membrane had reached a proper equilibration, the 
surface area per lipid was estimated in a manner consistent with Jo et al.
49
 by squaring the 
size of the x-dimension of the crystal and dividing by the total number of lipids per leaflet 
Figure 3.1 – Snapshot of the model yeast membrane.  Residues are color coded 
as follows: DOPC – red; DPPC – orange; POPA – blue; POPE – purple; POPS – 
red; ergosterol – yellow. Solvent atoms and hydrogens are not displayed here for 
clarity. Images in the x direction are shown as transparent. 
48 
 
(Figure 3.2). After approximately 40 ns, a plateau in the surface area per lipid was 
reached, and the following 20 ns were used to constitute the production run. During this 
period, the membrane achieved an average surface area per lipid of 50.3±0.3 Å
2
, which is 
slightly lower than the area of 51.6±0.2 Å
2
 reported for the CPR1 membrane 
simulations of Jo et al.
49
 However, the surface area per lipid for the model yeast 
membrane was nearly identical to a simulation of the CPR1 membrane using the C36 
force field that was conducted by Joseph Lim, a co-author of the Jo et al.
49
 paper (50.2 
Å
2
) . The surface areas per individual lipid type were calculated using Voroni tessellation 
in a manner presented in Pandit et al.
58
 and consistent with Jo et al.
48
 Three representative 
atoms on each phospholipid head group were chosen, both carbonyl carbons as well as 
the carbon where the two acyl chains connect to the phospholipid head group, and 
projected onto the z=0 plane. One representative atom on each ergosterol residue, the 
Figure 3.2 – Surface area (SA) per lipid over 60 ns of MD simulation.  
49 
 
Model Sterol DOPC DPPC POPA POPE POPS
Yeast-Ergosterol 29.1 ± 0.6 56.9 ± 0.8 57.0 ± 0.9 55.0 ± 1.2 55.7 ± 1.1 55.3 ± 1.5
CPRΔ1 (Jo et al.) 30.7 ± 0.2 58.9 ± 0.3 55.6 ± 0.5 56.4 ± 0.6 57.8 ± 0.4 53.9 ± 1.0
CPRΔ1 - C36 28.7 ± 0.7 57.2 ± 0.7 55.4 ± 1.6 56.3 ± 1.6 55.9 ± 0.8 53.7 ± 2.1
SA [Å2]
hydroxyl oxygen, was projected onto the z=0 plane. A Delaunay triangulation was 
constructed for these points, and the circumcenters were calculated and used as the 
coordinates for the Voroni polygons of the representative atoms used for surface area 
calculations. These calculations were conducted using the Quickhull program.
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Calculated surface areas per individual lipid types are presented in Table 3.1. Most lipid 
types display similar surface areas when compared with Jo et al,.
49
 though ergosterol and 
DOPC show lower surface areas in these simulations. There are no statistically 
significant differences in residue specific surface area between the ergosterol simulation 
and a simulation of the CPR1 membrane using the C36 force field that was conducted 
by Joseph Lim. 
 Electron density profiles were calculated using the method described in Feller et 
al.
60
 That is, trajectory snapshots were binned into 0.1 Å thick slabs and time averaged to 
calculate the number of electrons per slab. The total electron density profile is displayed 
in Figure 3.3A, and shows three distinct regions. The first occurs when |z| is above 
approximately 30 Å from the center of the bilayer (z = 0 Å), and is represented by a 
plateau of ~0.34 e Å
-3
. This region corresponds to the bulk water phase. The second 
region corresponds to the phospholipid head groups, and is represented as a peak which 
Table 3.2 – Surface area (SA) per lipid by residue type. CPR1 data is taken from Jo et al. CPR1 – C36 
data is taken from simulations of the CPR1 membrane using the C36 force field that was conducted by 
Joseph Lim, a co-author of the Jo et al. paper. 
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reaches a maximum at |z| ~ 22.6 Å. The third region is a low density trough between the 
two membrane leaflets at z = 0 Å. The peak-to-peak spacing (XHH) was found to be 45.20 
± 0.2 Å, which is slightly larger than the value reported for the CPRmembrane (43.0 
Å) presented in Jo et al.
49
 and also slightly larger than the value reported for the CPR1-
C36membrane simulated by Joseph Lim (43.3 ± 0.2 Å). The normalized electron density 
profiles for each phospholipid are presented in Figure 3.3B. Unlike the 
CPRmembrane from Jo et al.,
49
 DOPC did not have the highest density at the center of 
the bilayer. For this simulation, POPA showed the highest density at the bilayer center, 
followed by POPE, DOPC, POPS, and DPPC. POPS displayed the largest head group 
distribution as well as the highest preference for the water phase, as indicated by having 
the head group distribution the farthest away from the membrane center. 
Figure 3.3 – Electron density profiles for the model yeast membrane. A, The electron density profile of all 
system components, including solvent. Regions are marked as follows: i – bulk water phase; ii – 




 The |SCD| is a measurement of the average angle of the C-H vector with respect to 
the membrane bilayer normal. A higher |SCD| corresponds to a higher degree of C-H 
ordering.
49
  The |SCD| for each phospholipid type used in this study was calculated using 
Equation 3.1: 
       
 
 
                                                                    
The |SCD| order parameters for each individual lipid are shown in Figure 3.4, and the |SCD| 
of individual hydrogens on each phospholipids C2 carbon are listed in Table 3.2. Chain 
splitting on the C2 carbon is observed for all phospholipids for this simulation, which was 
not observed in the Jo et al.
49
 simulations using the CHARMM C27r force field. While 
most phospholipids with a monounsaturated bond in one of the side chains displayed 
statistically indistinguishable, or at least highly similar, |SCD| between the C9 and C10 
carbons, a difference between the |SCD| 
between the C9 and C10 carbons existed. 
POPS displayed the highest |SCD| of all 
oleolyl chains beyond the C9-C10 double 
bond while displaying the lowest |SCD| of 
all oleolyl chains before this bond. 
 The orientation of ergosterol with 
respect to the membrane bilayer normal 
was calculated by defining a vector over 
the sterol ring structure through 
ergosterol’s C3 and C17 carbons. The C3 
Lipid type H2R H2S
DOPC 0.26 ± 0.002 0.26 ± 0.003
DPPC 0.26 ± 0.01 0.26 ± 0.01
POPA 0.30 ± 0.004 0.26 ± 0.01
POPE 0.27 ± 0.004 0.25 ± 0.004
POPS 0.28 ± 0.01 0.27 ± 0.01
Lipid type H2R H2S
DOPC 0.07 ± 0.15 0.01 ± 0.005
DPPC 0.09 ± 0.13 0.01 ± 0.01
POPA 0.10 ± 0.13 0.01 ± 0.01
POPE 0.08 ± 0.01 0.16 ± 0.01
POPS 0.14 ± 0.01 0.16 ± 0.01
Chain 1
Chain 2
Table 3.3 – SCD order parameters for individual 
hydrogens of the C2 carbon. For carbon numbering 
nomenclature, see Appendix. 
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and C17 carbon positions on ergosterol are 
labeled in Figure 2.7.  The probability 
distribution of ergosterol’s tilt angle is 
shown in Figure 3.5. The mean tilt angle 
was found to be 18.0° with a most probable 
angle of 15°. The mean tilt angle reported 
here is similar to that of the 
CPRmembrane from Jo et al. (18.6°).
49
 
However, the CPR1-C36 simulations 
conducted by Joseph Lim reveal a mean 
cholesterol tilt angle of 16.5° with a most 
probable angle of 12°. Ergosterol was 
found to posses a 15° tilt of the inertial axis 
with respect to the diffusional access in 
13
C-labeled NMR experiments of 16% 
ergosterol in a DMPC bilayer.
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Figure 3.4 – SCD order parameters for all 
phospholipids. Order parameters for individual 













Figure 3.5 – Probability distribution of the tilt angle 
of ergosterol and cholesterol. Choelsterol data is 




CHAPTER 4 – DISCUSSION AND CONCLUSIONS 
 
 The discussion of results and conclusions drawn from the simulations presented 
within this text are presented in two separate sections: one section accounts for Osh4 
specific work and the other for membrane specific work. Both the Osh4 and membrane 
work are inherently important to the ultimate goal of this project, that is, simulating a 
combined protein and membrane system (see Chapter 5, ‘Future Directions’). However, 
for the purposes of this text, the Osh4 and membrane simulations are separated and 
treated as separate entities within this section for improved clarity. 
4.1 The Osh4 Protein 
 The sterol binding energetics observed in the Osh4/ergosterol MD simulations 
were similar to previous MD studies on Osh4/cholesterol conducted in Singh et al.
28
 
Ergosterol remained tightly bound within the Osh4 binding pocket throughout the course 
of all simulations, with binding energies dominated by vdW interactions (83%). The F42 
side chain, which is located near each sterol’s ring structure, is the dominant vdW 
contributing term (-4.0±0.2 kcal/mol). This residue forms an edge-to-face stacking 
interaction with ergosterol’s ring structure while other nonpolar residues within the 
binding pocket further stabilize the hydrophobic portion of ergosterol. Similar proline 
edge-to-face interactions were also seen with P110 (-1.9±0.1 kcal/mol), which is located 
perpendicular to ergosterol’s five membered ring. 
 Though there was some minor interaction between F13 and ergosterol’s tail 
(Table 2.3), hydrophobic residues on the helical portion of the protein’s lid (W10, L14, 
I17, and F20) did not contribute to the total binding energy to any significant degree. 
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Ergosterol was primarily stabilized through vdW interactions with hydrophobic residues 
near the top of the binding pocket (L24, I33, L177, I206, and P211) as well as three 
nearby charged residues (E107, K108, K109). These simulations do not support the 
suggestion that hydrophobic residues on the lid directly stabilize the sterol within the 
binding pocket to any notable degree. However, these residues may stabilize the bound 
sterol indirectly by occluding the hydrophobic portion of the sterol from unfavorable 
solvent interaction. Of the three charged residues displaying the most favorable sterol 
interaction, only E107 posses a side chain that faces towards the inside of the binding 
pocket. These three residues, especially E107, demonstrated the greatest differences 
between ergosterol versus cholesterol binding. Given that the largest structural 
differences between cholesterol and ergosterol occur in the tail, these residues may be 
important in allowing the binding pocket to accommodate a wide range of sterols. Only 




 As in Singh et al.,
28
 water-mediated interactions between the 3-OH group of 
ergosterol and polar residues on the bottom the binding pocket (W46, Q96, Y97, N165, 
and Q181) were more prevalent than direct hydrogen bonding. Only Q96 was able to 
form direct hydrogen bonds with ergosterol to any significant degree, though water-
mediated interactions were still more common than direct hydrogen bonding for this 
residue. Waters initially present within the sterol binding pocket during the start of each 
simulation did not leave the bottom of the binding pocket. Occasionally, water molecules 
from the bulk phase were able to pass through small gaps between the Osh4 lid and the 
binding pocket. These waters quickly moved towards the bottom of the binding pocket 
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and became coordinated with waters already present in the pocket and the 3-OH group of 
ergosterol. 
 The structure of Osh4 remained stable throughout the course of MD simulation, 
as indicated by the RMSD of the protein’s carbon backbone atoms (2.09±0.26 Å). 
However, certain regions of the protein were flexible. One of these regions, the N-
terminal lid (residues 1-29), has been suggested to form an ALPS motif in a recent 
bioinformatics search.
24
 The 367-381 loop connecting the 8 and 18 sheet also showed a 
high level of flexibility. This loop exhibited multiple conformations for many of the MD 
trajectories, many of which appear unrelated, suggesting that this region may possibly be 
intrinsically disordered. Any functional consequence of this apparent disorder observed 
in this region is unknown. 
 The 236-244 loop was also shown to adopt a multitude of conformations, though 
these conformations tended to exhibit a higher degree of stability than those of the 367-
381 loop (Figure 2.4). Two main conformations were found: a folded state that is present 
in the crystal structure and an extended state characterized by a dramatic shift in both the 
hydrogen bonding patterns of select backbone atoms as well as the Ramachandran angles 
of glycine residues within the loop (Figure 2.6). In the extended conformation, F239 
extends away from the protein and into the solvent. While this extension would be 
energetically unfavorable in solvent, it may aid membrane attachment through favorable 
interactions with the hydrophobic portion of a membrane bilayer. Several known 
membrane binding domains, such as typical C1, FYVE, PX, and epsin ENTH domains 
exhibit hydrophobic protrusions that penetrate into the membrane and help stabilize the 
bound protein-membrane complex.
26
 The model PIP2 ligand was able to dock to the 
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folded conformation with a slightly higher affinity than the extended, with a difference in 
G
bind
 of 1-2 kcal/mol between the two conformations. Blind docking tests against the 
entire Osh4 surface using PIP2 and PIP3 model ligands located a potential binding region 
loop, in a lysine rich crease centered near K180 (-crease region). Given the high 
concentration of positively charged residues in this region, it is possible that a PIP 
binding event in this region may be driven by long-range electrostatic steering. 
 During brief MD simulations, PIP2 did not unbind from this region, though shifts 
in lysine-phosphate interactions indicate that the initial positioning of the PIP2 residue 
with respect to the protein was imperfect (Figure 2.13B). It remains unclear how PIP 
binding to the -crease region or the proximal 236-244 loop could facilitate sterol uptake 
and release from a membrane, given that the locations of both regions lie on a side of the 
protein that does not run parallel to the mouth of the Osh4 binding pocket. It is possible 
that PIP binding is accompanied by some conformational change that positions the mouth 
of the sterol binding pocket in close contact with the membrane or a possible pivot 
mechanism.
39
 The 236-244 loop as well as many residues identified in the -barrel 
portion of the -crease region fall within a fragment of the protein, residues 171-314, that 
posses the ability to bind to PIP2 and IP3.
27
 Furthermore, the -crease region contains 




 The -crease region (Table 2.4 and Figure 2.10) was favorable towards all lipid 
moieties tested (PC, PS, PIP2, and PIP3), suggesting that this region of the protein would 
interact favorable with a membrane in close contact. Negatively charged head groups 
(PS, PIP2, and PIP3) had a stronger affinity to this region of Osh4. It has been suggested 
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that two to three membrane binding surfaces exist on the surface of this protein: a front or 
lid-area binding surface, a distal binding surface, and a possible third surface along the 
236-244 loop (Figure 2.10B).
39
 The -crease region either includes or is adjacent to 
several residues identified in the front binding surface (A169, S174, and E412). However, 
a few key residues (S8 and N330) contained on the front binding surface are distant from 
all residues found in the -crease region. Furthermore, the -crease region does not fall 
on the plane formed by the front binding surface over the mouth of the binding pocket, 
suggesting that the -crease region is distinct from this surface. As the -crease region is 
located in proximity to the 236-244 loop, it is conceivable that if the protein were to bind 
to a membrane along -crease region, the 236-244 loop would be in close contact with 
the membrane as well. 
 The docking of model lipids to the engineered lidless protein structure 
demonstrated that all lipid moieties studied were able to dock near the mouth of the 
binding pocket (mouth and 4 region). Lipid binding towards the residues implicated in 
these site agrees with the proposed mechanism for Osh4-mediated sterol transport 
suggested by Im et al.
23
 That is, charged residues on the mouth of the binding pocket bind 
to the membrane while the protein is in the lid-open state, allowing for a sterol within the 
membrane to transfer into the Osh4 binding pocket. Several lipid residues identified 
within the mouth region (K109, L111, and K336) have been found to be important in 
sterol transfer between liposomes, especially with PIP2-containing membranes.
14
 While 
multiple regions of phospholipid affinity were encountered along the Osh4 surface, 
residues of the 7 helix as well as the distal binding surface were not captured in our 
docking studies. This is attributed to the lack of flexibility for backbone atoms along the 
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Osh4 surface available in these docking studies and suggests protein conformational 
changes are required to bind to the membrane in these experimentally proposed regions. 
However, many of the regions identified in our docking tests (Table 2.4 and Table 2.5) 
are either in or near a conformation that can attract a membrane. 
 Schulz et al.
39
 suggested that the Osh4 protein may pivot between closely apposed 
membranes, such as an ER-PM membrane contact site, based on experiments where Osh4 
was covalently bonded to a membrane with varying linker lengths. Our work predicts a 
membrane binding surface, the -crease region, that is located between both the proposed 
front and distal binding surfaces. This agrees well with the Schulz et al.
39
 cross-linking 
results, and would provide for a surface that could facilitate or initiate pivoting between 
closely apposed membranes. 
 It may be possible that PIP2 binding to the 236-244 loop or a nearby region, such 
as the -crease region, could trigger a lid opening event and allow the protein to pivot to 
a position where nearby mouth residues can bind to the membrane. Such a mechanism 
would agree with the results from Li et al.,
27
 in that the 171-314 region would be subject 
to PIP2 binding, as well as the results from Schulz et al.,
39
 in that the protein would be 
able to pivot between membranes so as to move sterols between them. However, the 
mechanism whereby Osh4 is able to transfer sterols between membranes remains 
unknown. 
4.2 The Model Yeast Membrane  
 The C36 force field was designed as an improvement over the C27/C27r force 
fields for several physical properties of phospholipid membrane systems, one of which 
being the surface area per lipid for a given system.
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) was lower than the CPR1 model membrane from Jo et al.,
49
 with one 
phospholipid (DOPC) displaying a statistically significant lower surface area per lipid in 
the ergosterol simulations. However, there were no differences in surface areas per lipid 
between the model ergosterol membrane and the CPR1-C36 model simulated by Joseph 
Lim (Table 3.2). Differences between the overall surface area per lipid between CPR1-
C36 and CPR1-C27r model systems are caused by the changes to the C36 force field.  
The condensing effect of ergosterol has been observed to be greater than that of 
cholesterol in both experimental and computational studies.
5; 62
 However, these ordering 
effects were observed in bilayers that consisted of PC lipids with fully saturated acyl 
chains, such as DPPC and dimyristoylphosphatidylcholine (DMPC). While DPPC was 
present in this model system, it only constituted 7.4% of the total membrane lipids and 
9.5% of the total membrane phospholipids. The remaining phospholipids contained at 
least one unsaturated chain. 
Ergosterol was found to be inferior to cholesterol in terms of condensing effects 
in NMR spectroscopy analysis of a 30% sterol, 70% palmitoyloleoylphosphatidylcholine 
(POPC) bilayer.
62
 While all lipids in the model yeast membrane containing one 
unsaturated side chain (POPA, POPE, and POPS) had similar surface areas when 
compared against their CPR1-model counterparts, DOPC displayed a lower surface area 
for the ergosterol simulations. The presence of unsaturated acyl chains within a 
membrane bilayer is thought to have a complicated relationship with a sterol’s ability to 
condense the bilayer.
62
 Currently, no experimental data is available that directly 
compares the membrane condensing effects of cholesterol and ergosterol on DOPC. 
However, the data presented here suggests that the relationship between membrane 
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condensing, sterol structure, and phospholipid chain saturation is complex, and is further 
complicated by the presence of the non-homogeneity of a membrane with several distinct 
lipid types.  
 In the CPR1-C27r force field simulations in Jo et al.,
49
 |SCD| values on the chain 
one C2 carbon, with the exception of POPS, do not show the proper trend. That is, for 
these simulations, the |SCD| of the C2 carbon is lower than the |SCD| of the C3 carbon where 
the opposite should be true.
63
 This chain splitting on the C2 carbon is more accurately 
represented in this ergosterol simulation using the C36 force field (Figure 3.4) when 
compared with the previous C27 and C27r force fields.
48; 54; 56
 Thus, the C36 force field 
provides a more accurate description of the lipid molecules intramolecular orientation 
with respect to the bilayer normal for atoms near the glycerol carbon region. As water 
molecules penetrate into this region of the membrane, properly reproducing the correct 
conformation in this region should be important with regards to simulating proper water-
lipid interactions.  
 Sterol tilt angles varied between cholesterol and ergosterol (Figure 3.5) across 
simulations using the C36 force field. Several previous simulation studies have 
investigated the differences in tilt angles between ergosterol and cholesterol in model 
membranes with mixed results. Smondyrev and Berkowitz
64
 found the average tilt to be 
higher for ergosterol when compared with cholesterol in a simulation with sterol 
containing DMPC bilayers using the AMBER forcefield.
22
 However, in simulations 
conducted by Cournia et al.,
5
 ergosterol showed a lower tilt angle than cholesterol. These 
simulations were conducted in CHARMM using the C27 force field and used DPPC 
bilayers. For the model membrane system studied here, ergosterol contained a tilt of 
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18.0°, which is higher than the tilt of cholesterol found in the CPR1-C36 simulation 
conducted by Joseph Lim. Because a smaller sterol tilt is attributed to a stronger ability to 
order membranes,
65
 this data suggests that cholesterol produces a greater ordering affect 
than ergosterol in this membrane system.   
 As in Cournia et al.,
5
 the thickness of the membrane bilayer, as measured by the 
electron density profile, was higher in the ergosterol simulation than for the CPR1-C36 
simulation by Joseph Lim by 1.9 Å. A slight increase (~1 Å) in membrane thickness of 
DMPC bilayers with 20% mol ergosterol over bilayers with 20% mol cholesterol was 
also observed in a small-angle neutron scattering study.
66
 One possible explanation for 
this increase in membrane thickness, as touched on in Pencer et al.,
66
 is that the presence 
of ergosterol has a greater ability to restrict the tilt of the phospholipid acyl chains. As 
mentioned earlier, the increased tilt angle of ergosterol over cholesterol implies that 
cholesterol is better at ordering this membrane system. With the exception of the sn-1 
chain of DOPC where ergosterol was found to produce increased ordering over the entire 
chain, SCD  parameters on the oleoyl phospholipid chains generally displayed increased 
ordering with cholesterol in the region between the head group and the C9-C10 double 
bond while ergosterol displayed increased ordering below this region (based on z-test 
with ≤0.05). Palmatoyl chains generally showed better ordering with cholesterol, 
though differences were commonly statistically insignificant at the =0.05 level below 
the first few carbons. It would normally be expected that the reduced ordering with 
ergosterol would also produce a thinner membrane. However, disruption of the tilt of the 
individual phospholipids by ergosterol would account for the increase in bilayer thickness 





CHAPTER 5 – FUTURE DIRECTIONS 
 
While the docking studies presented here provide insight into where a membrane 
would bind along the Osh4 surface, they only suggest potential mechanisms for 
membrane binding and sterol transfer. In order to more completely understand how Osh4 
mechanistically attaches to PIP-containing membranes and then uptakes or releases a 
single ergosterol molecule, MD simulations of a combined protein-membrane system will 
be employed. These simulations will require organelle specific model yeast membranes 
to be constructed, in part, through use of the CHARMM-GUI Membrane Builder.
49
 
Currently, the CHARMM-GUI Membrane Builder does not support PI lipids, which play 
a key role in facilitating Osh4’s ability to bind to transfer sterols between vesicles in 
vitro.
14
 This problem can be circumnavigated by constructing a membrane in CHARMM-
GUI and mutating specific residues as needed before membrane equilibration. 
The model yeast membrane presented here is based on the percentages of 
phospholipid head groups and fatty acids taken from whole yeast cells.
57
 Thus, this model 
is more representative of an average across all yeast organelles. In order to model Osh4 
attachment to different membranes within the cell, two membranes would be needed: one 
to model the ER and one to model the PM. In yeast, the PM is enriched with negatively 
charged PS lipids while the ER is enriched with charge-neutral PC lipids.
41; 46
 Osh4 will 
be placed in close contact with each membrane in three orientations that model both the 
lid binding surface and distal binding surface described in Schulz et al.
39
 as well as the 
intermediate, -crease region that is described here. 
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As Osh4 has demonstrated the ability to attach to two membranes simultaneously 
at membrane contact sites, additional simulations will be performed in a dual membrane 
system. For these simulations, Osh4 will be placed in between a model ER monolayer 
and a model PM monolayer. Two simulations will be performed, one with the front 
binding surface in contact with the ER and the distal surface in contact with the PM and 
another simulation where the surfaces are switched. This will provide a better 
understanding on how Osh4 binds to membranes simultaneously, as well as allow for the 
investigation of the proposed pivoting mechanism for sterol transfer between closely 
apposed membranes suggested in Schulz et al.
39
 In order to allow for changes in the Osh4 
tertiary structure as well as membrane equilibration, longer simulation timescales will be 
needed than those presented in the simulations here. While all atom MD simulations of 
systems of this size are limited to ~100 ns, course-grained force fields are able to 
approach timescales of multiple microseconds.
67
 However, with the appropriate 
computational hardware and allocation, MD simulations of the microsecond time scales 
are obtainable. 
Understanding the mechanism by which the Osh4 protein transports sterols 
between membranes will provide important insight into how proper intracellular sterol 
gradients between membrane organelles are maintained. Given the high sequential 
homology between the Osh proteins in yeast and similar ORP proteins in mammals, 
investigation of sterol transport pathways in yeast will aid in understanding these 
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